HB Wealth Management LLC Sells 5,851 Shares of GE HealthCare Technologies Inc. $GEHC

Key Points

• HB Wealth Management LLC has cut its holdings in GE HealthCare Technologies Inc. by 46.1%, selling 5,851 shares and leaving them with 6,831 shares valued at approximately $506,000.
• GE HealthCare Technologies reported earnings of $1.06 per share for the last quarter, surpassing analysts' expectations of $0.91, with revenue increasing by 3.5% year-over-year.
• The company announced a quarterly dividend of $0.035 per share, with a dividend yield of 0.2%, reflecting a payout ratio of 2.87%.

HB Wealth Management LLC cut its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 46.1% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 6,831 shares of the company's stock after selling 5,851 shares during the quarter. HB Wealth Management LLC's holdings in GE HealthCare Technologies were worth $506,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also made changes to their positions in the company. N.E.W. Advisory Services LLC bought a new position in shares of GE HealthCare Technologies during the first quarter valued at approximately $25,000. Bogart Wealth LLC boosted its stake in shares of GE HealthCare Technologies by 260.0% during the 1st quarter. Bogart Wealth LLC now owns 342 shares of the company's stock worth $28,000 after acquiring an additional 247 shares during the last quarter. Stonebridge Financial Group LLC boosted its stake in shares of GE HealthCare Technologies by 165.7% during the 1st quarter. Stonebridge Financial Group LLC now owns 356 shares of the company's stock worth $29,000 after acquiring an additional 222 shares during the last quarter. Olde Wealth Management LLC bought a new stake in GE HealthCare Technologies during the first quarter valued at about $35,000. Finally, Zions Bancorporation National Association UT bought a new stake in GE HealthCare Technologies during the first quarter valued at about $42,000. Institutional investors own 82.06% of the company's stock.

GE HealthCare Technologies Stock Performance

NASDAQ:GEHC opened at $76.56 on Monday. The firm has a market capitalization of $34.95 billion, a price-to-earnings ratio of 15.69, a PEG ratio of 2.93 and a beta of 1.13. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.16 and a quick ratio of 0.93. GE HealthCare Technologies Inc. has a 1-year low of $57.65 and a 1-year high of $94.80. The company's 50-day moving average is $74.25 and its two-hundred day moving average is $72.48.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last released its quarterly earnings results on Wednesday, July 30th. The company reported $1.06 EPS for the quarter, topping analysts' consensus estimates of $0.91 by $0.15. GE HealthCare Technologies had a return on equity of 23.93% and a net margin of 11.22%.The company had revenue of $5 billion for the quarter, compared to analysts' expectations of $4.96 billion. During the same period in the prior year, the firm earned $1.00 earnings per share. The firm's revenue was up 3.5% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. Analysts forecast that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, November 14th. Investors of record on Friday, October 24th will be paid a dividend of $0.035 per share. The ex-dividend date is Friday, October 24th. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. GE HealthCare Technologies's payout ratio is presently 2.87%.

Analyst Upgrades and Downgrades

GEHC has been the topic of several research analyst reports. BTIG Research reiterated a "buy" rating on shares of GE HealthCare Technologies in a research note on Monday, July 14th. Citigroup upped their target price on shares of GE HealthCare Technologies from $89.00 to $93.00 and gave the stock a "buy" rating in a research note on Thursday, July 31st. Weiss Ratings restated a "hold (c)" rating on shares of GE HealthCare Technologies in a research note on Saturday, September 27th. Zacks Research cut shares of GE HealthCare Technologies from a "strong-buy" rating to a "hold" rating in a research report on Monday, September 29th. Finally, Morgan Stanley set a $74.00 target price on shares of GE HealthCare Technologies in a research report on Thursday, September 18th. Seven equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $86.89.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.

Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.